246 related articles for article (PubMed ID: 28581517)
1. Functional antagonism of β-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes.
Suleymanova N; Crudden C; Shibano T; Worrall C; Oprea I; Tica A; Calin GA; Girnita A; Girnita L
Oncogene; 2017 Oct; 36(41):5734-5744. PubMed ID: 28581517
[TBL] [Abstract][Full Text] [Related]
2. Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor.
Zheng H; Worrall C; Shen H; Issad T; Seregard S; Girnita A; Girnita L
Proc Natl Acad Sci U S A; 2012 May; 109(18):7055-60. PubMed ID: 22509025
[TBL] [Abstract][Full Text] [Related]
3. {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase.
Girnita L; Shenoy SK; Sehat B; Vasilcanu R; Girnita A; Lefkowitz RJ; Larsson O
J Biol Chem; 2005 Jul; 280(26):24412-9. PubMed ID: 15878855
[TBL] [Abstract][Full Text] [Related]
4. β-Arrestin-biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor-targeting antibodies in Ewing's sarcoma.
Zheng H; Shen H; Oprea I; Worrall C; Stefanescu R; Girnita A; Girnita L
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20620-5. PubMed ID: 23188799
[TBL] [Abstract][Full Text] [Related]
5. Beta-arrestin1 and beta-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of delta-opioid receptors.
Zhang X; Wang F; Chen X; Li J; Xiang B; Zhang YQ; Li BM; Ma L
J Neurochem; 2005 Oct; 95(1):169-78. PubMed ID: 16181421
[TBL] [Abstract][Full Text] [Related]
6. Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression.
Girnita L; Shenoy SK; Sehat B; Vasilcanu R; Vasilcanu D; Girnita A; Lefkowitz RJ; Larsson O
J Biol Chem; 2007 Apr; 282(15):11329-38. PubMed ID: 17303558
[TBL] [Abstract][Full Text] [Related]
7. Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor.
Girnita A; Zheng H; Grönberg A; Girnita L; Ståhle M
Oncogene; 2012 Jan; 31(3):352-65. PubMed ID: 21685939
[TBL] [Abstract][Full Text] [Related]
8. Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation.
Girnita L; Worrall C; Takahashi S; Seregard S; Girnita A
Cell Mol Life Sci; 2014 Jul; 71(13):2403-27. PubMed ID: 24276851
[TBL] [Abstract][Full Text] [Related]
9. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
[TBL] [Abstract][Full Text] [Related]
10. Differential and competitive regulation of human melanocortin 1 receptor signaling by β-arrestin isoforms.
Abrisqueta M; Herraiz C; Pérez Oliva AB; Sanchez-Laorden BL; Olivares C; Jiménez-Cervantes C; García-Borrón JC
J Cell Sci; 2013 Aug; 126(Pt 16):3724-37. PubMed ID: 23750009
[TBL] [Abstract][Full Text] [Related]
11. Regulation of SOD2 and β-arrestin1 by interleukin-6 contributes to the increase of IGF-1R expression in docetaxel resistant prostate cancer cells.
Zhang D; Cui Y; Niu L; Xu X; Tian K; Young CY; Lou H; Yuan H
Eur J Cell Biol; 2014 Jul; 93(7):289-98. PubMed ID: 24939178
[TBL] [Abstract][Full Text] [Related]
12. IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma.
Song D; Cismas S; Crudden C; Trocme E; Worrall C; Suleymanova N; Lin T; Zheng H; Seregard S; Girnita A; Girnita L
Oncogene; 2022 Jan; 41(4):600-611. PubMed ID: 34785779
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of G Protein-Coupled Receptor Kinase 2 Promotes Unbiased Downregulation of IGF1 Receptor and Restrains Malignant Cell Growth.
Crudden C; Shibano T; Song D; Dragomir MP; Cismas S; Serly J; Nedelcu D; Fuentes-Mattei E; Tica A; Calin GA; Girnita A; Girnita L
Cancer Res; 2021 Jan; 81(2):501-514. PubMed ID: 33158816
[TBL] [Abstract][Full Text] [Related]
14. Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer.
Cao H; Dong W; Shen H; Xu J; Zhu L; Liu Q; Du J
PLoS One; 2015; 10(8):e0135844. PubMed ID: 26287334
[TBL] [Abstract][Full Text] [Related]
15. The viral G protein-coupled receptor ORF74 unmasks phospholipase C signaling of the receptor tyrosine kinase IGF-1R.
de Munnik SM; van der Lee R; Velders DM; van Offenbeek J; Smits-de Vries L; Leurs R; Smit MJ; Vischer HF
Cell Signal; 2016 Jun; 28(6):595-605. PubMed ID: 26931381
[TBL] [Abstract][Full Text] [Related]
16. The dichotomy of the Insulin-like growth factor 1 receptor: RTK and GPCR: friend or foe for cancer treatment?
Crudden C; Ilic M; Suleymanova N; Worrall C; Girnita A; Girnita L
Growth Horm IGF Res; 2015 Feb; 25(1):2-12. PubMed ID: 25466906
[TBL] [Abstract][Full Text] [Related]
17. Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and beta-arrestin1.
Vasilcanu R; Vasilcanu D; Rosengren L; Natalishvili N; Sehat B; Yin S; Girnita A; Axelson M; Girnita L; Larsson O
Oncogene; 2008 Mar; 27(11):1629-38. PubMed ID: 17828296
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma.
Zhang T; Shen H; Dong W; Qu X; Liu Q; Du J
Sci Rep; 2014 Oct; 4():6855. PubMed ID: 25358597
[TBL] [Abstract][Full Text] [Related]
19. Role of ubiquitination in IGF-1 receptor signaling and degradation.
Sehat B; Andersson S; Vasilcanu R; Girnita L; Larsson O
PLoS One; 2007 Apr; 2(4):e340. PubMed ID: 17406664
[TBL] [Abstract][Full Text] [Related]
20. Competing Engagement of β-arrestin Isoforms Balances IGF1R/p53 Signaling and Controls Melanoma Cell Chemotherapeutic Responsiveness.
Cismas S; Pasca S; Crudden C; Trocoli Drakensjo I; Suleymanova N; Zhang S; Gebhard B; Song D; Neo S; Shibano T; Smith TJ; Calin GA; Girnita A; Girnita L
Mol Cancer Res; 2023 Dec; 21(12):1288-1302. PubMed ID: 37584671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
